Agnieszka Gauthier
Psychiatry · Sharon, PANPI 1922219724
Payments from drug & device makers
Across 170 payments — averaging $16.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$482
- AbbVie$474
- Takeda Pharmaceuticals U.S.A., Inc.$325
- Johnson & Johnson$236
- Vanda Pharmaceuticals Inc.$212
- Sunovion Pharmaceuticals Inc.$195
- plus $961 from 14 others
What the payments were for
- Food & beverage$2,62291%
- Education$2659%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 21 | $482 |
| AbbVie(2 entities) | 32 | $474 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $325 |
| Johnson & Johnson | 14 | $236 |
| Vanda Pharmaceuticals Inc. | 12 | $212 |
| Sunovion Pharmaceuticals Inc. | 11 | $195 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $173 |
| Lundbeck LLC | 9 | $141 |
| Otsuka America Pharmaceutical, Inc. | 7 | $118 |
| Alkermes, Inc. | 5 | $107 |
| Axsome Therapeutics, Inc. | 4 | $98 |
| Neurocrine Biosciences, Inc. | 5 | $78 |
| Shire North American Group Inc | 5 | $75 |
| Indivior Inc. | 3 | $64 |
| Eisai Inc. | 2 | $34 |
| Neuronetics, Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $15 |
| Neos Therapeutics, LP | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $11 |
How this compares
$2,886 in reported general payments places this provider in the 85th percentile of 1,838 psychiatry providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 34 | $221,232 |
| IngrezzaValbenazine Tosylate | 23 | $187,482 |
| VraylarCariprazine Hcl | 70 | $95,696 |
| Invega SustennaPaliperidone Palmitate | 22 | $69,017 |
| TrintellixVortioxetine Hydrobromide | 143 | $63,269 |
| Abilify MaintenaAripiprazole | 20 | $56,953 |
| FanaptIloperidone | 12 | $43,846 |
| RexultiBrexpiprazole | 14 | $18,868 |
| LybalviOlanzapine/Samidorphan Malate | 11 | $16,052 |
| Aripiprazole | 292 | $8,769 |
| Divalproex Sodium ErDivalproex Sodium | 180 | $5,627 |
| Quetiapine Fumarate | 273 | $5,232 |
| Clorazepate Dipotassium | 18 | $5,183 |
| Lurasidone Hcl | 29 | $5,124 |
| Chlorpromazine Hcl | 18 | $5,111 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $482 | $221,23234 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $78 | $187,48223 claims |
| AbbVieVraylar | $474 | $95,69670 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $118 | $75,82134 claims |
| Johnson & JohnsonInvega Sustenna | $236 | $69,01722 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $325 | $63,269143 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $212 | $43,84612 claims |
| Alkermes, Inc.Lybalvi | $107 | $16,05211 claims |
| Supernus Pharmaceuticals, Inc.Qelbree | $15 | $4,19013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,838 psychiatry providers in Pennsylvania.
Other psychiatry in Sharon
- Cherian VergheseNorristown$16.3M
- Steven ArnoldPhiladelphia$4.1M
- Paul GrossAllentown$4.1M
- Shivkumar HattiMedia$4M
- Rebecca RomaPittsburgh$3.3M
- Matthew BergerMoosic$2.4M
- Michael ThasePhiladelphia$2.2M
- Robert NelsonWyomissing$2.2M
- Mark MattaNew Castle$847K
- Mayer AyyashPittsburgh$714K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.